• Home
  • A-B index
  • Pharmacological Index
  • Drug Classes
  • Active Ingredients
  • Companies
  • News
  • Nicotinell Lozenges
    / GSK

    Active Ingredient
    Nicotine 1 mg, 2 mg

    Status in Israel

    Presentation and Status in Health Basket

    Presentation Basket Yarpa Pharmasoft


    1 mg

    partial basket chart 13701 14452


    2 mg

    partial basket chart 38084 14547

    Related information


    Children and adolescents (< 18 years): Nicotinell lozenges should not be used by people under 18 years of age.
    Adults and elderly: Nicotinell Lozenges 1 mg is recommended in smokers with a low to moderate nicotine dependency. It is not recommended in the case of smokers with a strong or very strong nicotine dependency. Nicotinell Lozenges 2 mg is intended to be used by smokers with a strong or very strong nicotine
    dependency and those who have previously failed to stop smoking with the aid of nicotine replacement therapy.
    Method of administration:

    1. One lozenge to be sucked until the taste becomes strong.
    2. The lozenge should then be lodged between the gum and cheek.
    3. When the taste fades, sucking of the lozenge should commence again.
    4. The sucking routine will be adapted individually and should be repeated until the lozenge dissolves completely (about 30 minutes).
    Concomitant use of acidic beverages such as coffee or soda may decrease the buccal absorption of nicotine. Acidic beverages should be avoided for 15 minutes prior to sucking the lozenge.
    See package insert (OTC).


    As an aid to smoking cessation and for the relief of nicotine withdrawal symptoms in adults >18 years of age. In smokers currently unable or not ready to stop smoking abruptly, the lozenges may also be used as part of a program to reduce smoking prior to stopping completely.


    Hypersensitivity, non-smokers, below age of 18 years, phenylketonuria. See package insert (OTC).

    Special Precautions

    Pregnancy and lactation. See package insert (OTC).

    Side Effects

    See package insert (OTC).

    Drug interactions

    See package insert (OTC).